VAERS reports by lot

Pfizer COVID-19 lot EWO173: VAERS reports

63 VAERS reports list lot EWO173 as a Pfizer COVID-19 vaccine, received between 2021-04-30 and 2022-07-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
8%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6929%
Neurological4720%
Musculoskeletal2511%
Gastrointestinal2310%
Cardiac / Cardiovascular156%
Respiratory156%
Dermatological (non-injection-site)125%
Injection-site / Local reaction104%
Psychiatric / Neuropsychiatric83%
Allergic / Anaphylactic73%
Reproductive / Menstrual21%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California20
Indiana8
Washington6
Florida4
Massachusetts3
Virginia3
Colorado2
Oregon2
Maryland2
Hawaii1
Texas1
Michigan1

Reports by month received

2021-041
2021-0519
2021-067
2021-075
2021-0811
2021-095
2021-105
2021-121
2022-012
2022-022
2022-033
2022-051
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.